The company says K-Real utilizes a unique Multi Stage Oil (MSO) extraction process to ensure the oil’s freshness.
Enzymotec (Migdal HaEmeq, Israel) has introduced a new krill oil ingredient called K-Real that the company says utilizes a unique Multi Stage Oil (MSO) extraction process to ensure the oil’s freshness.
According to the company:
The decomposition process of fishery products is accompanied with an increased level of trimethylamine (TMA) and other compounds called total volatile basic nitrogen (TVN). TMA is responsible for the characteristic “fishy” odor of rotting fish, warning us of spoiled fish unfit for human consumption. In order to ensure public health, the EU authority (EFSA) recommended that total TVN levels not exceed 35mgN/100gr for unprocessed fishery products (decision 95/149/EC). MSO technology keeps undetectable levels of TVN in K-REAL (below 1 mgN/100 gr). Further it ensures greater stability of the product. Thus, it ensures full efficacy of the product during the course of its shelf life.
K-Real is also said to be highly potent. The ingredient is a 100% pure extract from Antarctic krill oil and is said to maintain the natural structure of krill phospholipids and omega-3 fatty acids EPA and DHA. It also contains astaxanthin.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.